TD Cowen initiated coverage on Reata Pharmaceuticals with a new price target
$RETA
Biotechnology: Pharmaceutical Preparations
Health Care
TD Cowen initiated coverage of Reata Pharmaceuticals with a rating of Outperform and set a new price target of $140.00